Evidence map›Paper›PMID 23071702›Full record

ArticlePloS one2012

Extracts of strawberry fruits induce intrinsic pathway of apoptosis in breast cancer cells and inhibits tumor progression in mice.

Ranganatha R Somasagara, Mahesh Hegde, Kishore K Chiruvella, Anjaneyulu Musini, Bibha Choudhary, Sathees C Raghavan

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 103 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Pharmaceuticals (Basel, Switzerland) · 2020
    Article
  19. Molecules (Basel, Switzerland) · 2020
    Review
  20. Medicina (Kaunas, Lithuania) · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Ranganatha R SomasagaraDepartment of Biochemistry, Indian Institute of Science, Bangalore, Karnataka, India.
Mahesh Hegde
Kishore K Chiruvella
Anjaneyulu Musini
Bibha Choudhary
Sathees C Raghavan
Indian Institute of Science Bangalore · INInstitute of Bioinformatics and Applied Biotechnology · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe consumption of berry fruits, including strawberries, has been suggested to have beneficial effects against oxidative stress mediated diseases. Berries contain multiple phenolic compounds and secondary metabolites that contribute to their biological properties. METHODOLOGY/PRINCIPAL

findingsCurrent study investigates the anticancer activity of the methanolic extract of strawberry (MESB) fruits in leukaemia (CEM) and breast cancer (T47D) cell lines ex vivo, and its cancer therapeutic and chemopreventive potential in mice models. Results of MTT, trypan blue and LDH assays suggested that MESB can induce cytotoxicity in cancer cells, irrespective of origin, in a concentration- and time-dependent manner. Treatment of mice bearing breast adenocarcinoma with MESB blocked the proliferation of tumor cells in a time-dependent manner and resulted in extended life span. Histological and immunohistochemical studies suggest that MESB treatment affected tumor cell proliferation by activating apoptosis and did not result in any side effects. Finally, we show that MESB can induce intrinsic pathway of apoptosis by activating p73 in breast cancer cells, when tumor suppressor gene p53 is mutated. CONCLUSIONS/SIGNIFICANCE: The present study reveals that strawberry fruits possess both cancer preventive and therapeutic values and we discuss the mechanism by which it is achieved.

Indexed as

FragariaAdenocarcinomaAge FactorsAnimalsAnticarcinogenic AgentsAntineoplastic Agents, PhytogenicApoptosisBH3 Interacting Domain Death Agonist ProteinBreast NeoplasmsCell Line, TumorChromosomal Proteins, Non-HistoneDNA-Binding ProteinsDose-Response Relationship, DrugDrug Screening Assays, AntitumorFemaleHumansAnticarcinogenic AgentsAntineoplastic Agents, PhytogenicBH3 Interacting Domain Death Agonist ProteinBid protein, mouseChromosomal Proteins, Non-HistoneDNA-Binding ProteinsKi-67 AntigenNuclear ProteinsPlant ExtractsTP73 protein, humanTrp53bp1 protein, mouseTrp73 protein, mouseTumor Protein p73Tumor Suppressor p53-Binding Protein 1Tumor Suppressor Proteins

Identifiers

PMID23071702
PMCPMC3468438
OpenAlexW2083368037

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.